SerenityShares Impact ETF ICAN 深 滬
已收盤 03-19 16:00:00 美东时间
28.485
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 28.485
- 總市值 427.00万
- 52周最高 29.8814
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 24.127
- 委 比 0.00%
- 總股本 14.99万
- 歷史最高 29.8814
- 量 比 0
- 振 幅 0.00%
- 歷史最低 24.127
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多XPO Q4 revenue beats on productivity improvements
XPO Q4 revenue beats on productivity improvements Overview Freight transportation firm's Q4 revenue rose 4.7%, beating analyst expectations Adjusted EPS for Q4 beat analyst expectations Adjusted EBITDA for Q4 beat analyst expectations Outlook XPO expects significant acceleration in free cash flow in
02-05 19:56
BRIEF-SEC Dismisses Proceedings Against American CryptoFed DAO
BRIEF-SEC Dismisses Proceedings Against American CryptoFed DAO Feb 5 (Reuters) - American CryptoFed DAO: SEC DISMISSES PROCEEDINGS AGAINST AMERICAN CRYPTOFED DAO Source text: ID:nPn70kGjSa (( Reuters.Briefs@thomsonreuters.com ;;))
02-05 06:44
BRIEF-JP Morgan Sees India Trimming Sanctioned Counterparties While Sustaining Russian Oil Flows
BRIEF-JP Morgan Sees India Trimming Sanctioned Counterparties While Sustaining Russian Oil Flows Feb 4 (Reuters) - JP MORGAN: IN ITS BASE CASE SAYS INDIA WILL LARGELY EXIT SANCTIONED COUNTERPARTIES BUT CONTINUE IMPORTING RUSSIAN CRUDE AT AROUND 0.8–1.0 MBD, ACCOUNTING FOR 17–21% OF TOTAL CRUDE IMPO
02-04 20:19
BRIEF-Mazda North American Operations Reported Total January Sales Of 28,958 Vehicles
BRIEF-Mazda North American Operations Reported Total January Sales Of 28,958 Vehicles Feb 3 (Reuters) - Mazda North American Operations: MAZDA NORTH AMERICAN OPERATIONS: REPORTED TOTAL JANUARY SALES OF 28,958 VEHICLES Source text: ID:nPn11ZkQva Further company coverage: 7261.T (( Reuters.Briefs@thom
02-04 00:05
BRIEF-Pfizer’S Ultra-Long-Acting Injectable Glp-1 RA Shows Weight Loss Results In Phase 2B Trial
BRIEF-Pfizer’S Ultra-Long-Acting Injectable Glp-1 RA Shows Weight Loss Results In Phase 2B Trial Feb 3 (Reuters) - Pfizer Inc PFE.N : PFIZER’S ULTRA-LONG-ACTING INJECTABLE GLP-1 RA SHOWS ROBUST AND CONTINUED WEIGHT LOSS WITH MONTHLY DOSING IN PHASE 2B TRIAL PFIZER’S ULTRA-LONG-ACTING INJECTABLE GLP-
02-03 21:21
BRIEF-Ultragenyx: Long-Term UX111 Data Shows Sustained CSF-HS Reductions, Multi-Domain Gains In Children With Sanfilippo Syndrome (Mps Iiia)
BRIEF-Ultragenyx: Long-Term UX111 Data Shows Sustained CSF-HS Reductions, Multi-Domain Gains In Children With Sanfilippo Syndrome (Mps Iiia) Feb 3 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O : ULTRAGENYX ANNOUNCES POSITIVE LONGER-TERM DATA DEMONSTRATING TREATMENT WITH UX111 GENE THERAPY RESULTS
02-03 21:09
WRAPUP 1-Post-holiday reordering boosts US manufacturing in January
WRAPUP 1-Post-holiday reordering boosts US manufacturing in January ISM manufacturing PMI rises to 52.6, highest since August 2022 New orders sub-index jumps to 57.1; employment contraction slows By Lucia Mutikani WASHINGTON, Feb 2 (Reuters) - U.S. factory activity grew for the first time in a year
02-03 01:56
BRIEF-Exxel Pharma Inc To Apply For NYSE American Listing
BRIEF-Exxel Pharma Inc To Apply For NYSE American Listing Feb 2 (Reuters) - EXXEL PHARMA INC - TO APPLY FOR NYSE AMERICAN LISTING - SEC FILING EXXEL PHARMA INC INTEND TO APPLY FOR LISTING OF OUR COMMON STOCK ON THE NYSE AMERICAN UNDER THE SYMBOL “EXXL”. EXXEL PHARMA INC SAYS JOSEPH GUNNAR & CO LLC I
02-02 19:34
UPDATE 1-Trump's pick to lead Fed faces early hurdle from Republican senator
UPDATE 1-Trump's pick to lead Fed faces early hurdle from Republican senator Updates throughout, adds Tillis block, background Tillis cites probe into Powell as reason to oppose Trump's Fed nominees North Carolina senator says Department of Justice's investigation is political interference Republica
01-31 01:15
BRIEF-American Express Expects FY EPS $17.30 To $17.90 VS IBES Estimate $17.41
BRIEF-American Express Expects FY EPS $17.30 To $17.90 VS IBES Estimate $17.41 Jan 30 (Reuters) - American Express Co AXP.N : AMERICAN EXPRESS Q4 TOTAL REVENUE NET OF INTEREST EXPENSE $18.98 BILLION VERSUS IBES ESTIMATE $18.92 BILLION AMERICAN EXPRESS Q4 EPS $3.53 VERSUS IBES ESTIMATE $3.54 AMERICAN
01-30 20:00
